1. Home
  2. STVN vs LITE Comparison

STVN vs LITE Comparison

Compare STVN & LITE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • LITE
  • Stock Information
  • Founded
  • STVN 1949
  • LITE 2015
  • Country
  • STVN Italy
  • LITE United States
  • Employees
  • STVN N/A
  • LITE N/A
  • Industry
  • STVN Containers/Packaging
  • LITE Telecommunications Equipment
  • Sector
  • STVN Consumer Discretionary
  • LITE Telecommunications
  • Exchange
  • STVN Nasdaq
  • LITE Nasdaq
  • Market Cap
  • STVN 5.7B
  • LITE 5.7B
  • IPO Year
  • STVN 2021
  • LITE N/A
  • Fundamental
  • Price
  • STVN $21.55
  • LITE $60.00
  • Analyst Decision
  • STVN Buy
  • LITE Buy
  • Analyst Count
  • STVN 6
  • LITE 15
  • Target Price
  • STVN $25.08
  • LITE $81.13
  • AVG Volume (30 Days)
  • STVN 334.9K
  • LITE 3.1M
  • Earning Date
  • STVN 05-08-2025
  • LITE 05-05-2025
  • Dividend Yield
  • STVN 0.27%
  • LITE N/A
  • EPS Growth
  • STVN N/A
  • LITE N/A
  • EPS
  • STVN 0.45
  • LITE N/A
  • Revenue
  • STVN $1,143,012,735.00
  • LITE $1,413,900,000.00
  • Revenue This Year
  • STVN $8.42
  • LITE $20.88
  • Revenue Next Year
  • STVN $10.36
  • LITE $29.21
  • P/E Ratio
  • STVN $47.85
  • LITE N/A
  • Revenue Growth
  • STVN 1.72
  • LITE N/A
  • 52 Week Low
  • STVN $16.56
  • LITE $38.29
  • 52 Week High
  • STVN $28.77
  • LITE $104.00
  • Technical
  • Relative Strength Index (RSI)
  • STVN 52.82
  • LITE 52.45
  • Support Level
  • STVN $21.13
  • LITE $55.00
  • Resistance Level
  • STVN $22.46
  • LITE $60.28
  • Average True Range (ATR)
  • STVN 1.25
  • LITE 4.74
  • MACD
  • STVN 0.07
  • LITE 1.18
  • Stochastic Oscillator
  • STVN 75.56
  • LITE 81.81

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

Share on Social Networks: